Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study.

Tirelli C, Morandi V, Valentini A, La Carrubba C, Dore R, Zanframundo G, Morbini P, Grignaschi S, Franconeri A, Oggionni T, Marasco E, De Stefano L, Kadija Z, Mariani F, Codullo V, Alpini C, Scirè C, Montecucco C, Meloni F, Cavagna L.

Front Med (Lausanne). 2020 Feb 18;7:11. doi: 10.3389/fmed.2020.00011. eCollection 2020.

2.

One year in review 2019: idiopathic inflammatory myopathies.

Tripoli A, Marasco E, Cometi L, De Stefano L, Marcucci E, Furini F, Barsotti S, Cavagna L.

Clin Exp Rheumatol. 2020 Jan-Feb;38(1):1-10. Epub 2020 Feb 3. Review.

3.

Influence of MUC5B gene on antisynthetase syndrome.

López-Mejías R, Remuzgo-Martínez S, Genre F, Pulito-Cueto V, Rozas SMF, Llorca J, Fernández DI, Cuesta VMM, Ortego-Centeno N, Gómez NP, Mera-Varela A, Martínez-Barrio J, López-Longo FJ, Mijares V, Lera-Gómez L, Usetti MP, Laporta R, Pérez V, Gafas AP, González MAA, Calvo-Alén J, Romero-Bueno F, Sanchez-Pernaute O, Nuno L, Bonilla G, Balsa A, Hernández-González F, Grafia I, Prieto-González S, Narvaez J, Trallero-Araguas E, Selva-O'Callaghan A, Gualillo O, Castañeda S, Cavagna L, Cifrian JM, González-Gay MA.

Sci Rep. 2020 Jan 29;10(1):1415. doi: 10.1038/s41598-020-58400-0.

4.

The Italian Society of Rheumatology clinical practice guidelines for the diagnosis and management of gout.

Ughi N, Prevete I, Ramonda R, Cavagna L, Filippou G, Manara M, Bortoluzzi A, Parisi S, Ariani A, Scirè CA.

Reumatismo. 2019 Sep 23;71(S1):50-79. doi: 10.4081/reumatismo.2019.1176.

5.

Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review.

Bellan M, Patrucco F, Barone-Adesi F, Gavelli F, Castello LM, Nerviani A, Andreoli L, Cavagna L, Pirisi M, Sainaghi PP.

Autoimmun Rev. 2020 Feb;19(2):102453. doi: 10.1016/j.autrev.2019.102453. Epub 2019 Dec 12.

PMID:
31838163
6.

Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis.

Giannini M, Grignaschi S, Fornaro M, Caporali R, Locatelli F, Zanframundo G, Meyer A, Montecucco C, Iannone F, Paolino S, Cavagna L.

Clin Exp Rheumatol. 2019 Dec 9. [Epub ahead of print]

PMID:
31820722
7.

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.

Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O'Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA.

J Clin Med. 2019 Nov 18;8(11). pii: E2013. doi: 10.3390/jcm8112013.

8.

The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives.

Furini F, Carnevale A, Casoni GL, Guerrini G, Cavagna L, Govoni M, Sciré CA.

Front Med (Lausanne). 2019 Oct 31;6:246. doi: 10.3389/fmed.2019.00246. eCollection 2019.

9.

Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis.

Franconeri A, Marasco E, Dore R, Codullo V, Calliada F, Disabella E, Meloni F, Zanframundo G, Montecucco C, Valentini A, Cavagna L.

Respir Med. 2019 Nov - Dec;160:105816. doi: 10.1016/j.rmed.2019.105816. Epub 2019 Nov 9.

PMID:
31739247
10.

[Thromboembolic vein disease (TVD): antithrombotic therapy choice in ASL TO3.]

Cavagna L, Falcone U, Dalmasso M, Migliardi A, Altini A, Bena A, Cavallo MR.

Recenti Prog Med. 2019 Sep;110(9):426-435. doi: 10.1701/3215.31936. Italian.

PMID:
31593179
11.

Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.

Codullo V, Cova E, Pandolfi L, Breda S, Morosini M, Frangipane V, Malatesta M, Calderan L, Cagnone M, Pacini C, Cavagna L, Recalde H, Distler JHW, Giustra M, Prosperi D, Colombo M, Meloni F, Montecucco C.

J Control Release. 2019 Sep 28;310:198-208. doi: 10.1016/j.jconrel.2019.08.015. Epub 2019 Aug 17.

PMID:
31430501
12.

Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis.

Bruschi M, Bonanni A, Petretto A, Vaglio A, Pratesi F, Santucci L, Migliorini P, Bertelli R, Galetti M, Belletti S, Cavagna L, Moroni G, Franceschini F, Fredi M, Pazzola G, Allegri L, Sinico RA, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Ramoino P, Bianchini P, Puppo F, Pupo F, Negrini S, Mattana F, Emmi G, Garibotto G, Santoro D, Scolari F, Ravelli A, Tincani A, Cravedi P, Volpi S, Candiano G, Ghiggeri GM.

J Rheumatol. 2020 Mar;47(3):377-386. doi: 10.3899/jrheum.181232. Epub 2019 May 15.

PMID:
31092713
13.

Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study.

Crisafulli S, Sultana J, Ingrasciotta Y, Addis A, Cananzi P, Cavagna L, Conter V, D'Angelo G, Ferrajolo C, Mantovani L, Pastorello M, Scondotto S, Trifirò G.

Expert Opin Drug Saf. 2019 Jun;18(6):497-509. doi: 10.1080/14740338.2019.1614165. Epub 2019 May 22. Review.

PMID:
31059293
14.

Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study.

Bartoloni E, Bistoni O, Alunno A, Cavagna L, Nalotto L, Baldini C, Priori R, Fischetti C, Fredi M, Quartuccio L, Carubbi F, Montecucco C, Doria A, Mosca M, Valesini G, Franceschini F, De Vita S, Giacomelli R, Mirabelli G, Bini V, Gabrielli A, Catassi C, Gerli R.

J Clin Med. 2019 Apr 19;8(4). pii: E540. doi: 10.3390/jcm8040540.

15.

Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al.

Knitza J, Cavagna L, Schett G, Distler JHW.

Ann Rheum Dis. 2019 Apr 17. pii: annrheumdis-2019-215484. doi: 10.1136/annrheumdis-2019-215484. [Epub ahead of print] No abstract available.

PMID:
30995979
16.

[Real World Management of Gouty Arthritis: Clinical, Epidemiological and Comorbidity Data from 4016 Patients in Rhineland-Palatinate, Germany].

Triantafyllias K, Clasen M, Cavagna L, de Blasi M, Klonowski A, Schwarting A.

Dtsch Med Wochenschr. 2019 Apr;144(8):e51-e57. doi: 10.1055/a-0755-1341. Epub 2019 Apr 15. German.

PMID:
30986856
17.

High cardiovascular risk in mixed connective tissue disease: evaluation of macrovascular involvement and its predictors by aortic pulse wave velocity.

Triantafyllias K, de Blasi M, Lütgendorf F, Cavagna L, Stortz M, Weinmann-Menke J, Konstantinides S, Galle PR, Schwarting A.

Clin Exp Rheumatol. 2019 Nov-Dec;37(6):994-1002. Epub 2019 Apr 2.

PMID:
30943141
18.

Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay.

Cassaniti I, Cavagna L, Calarota SA, Adzasehoun KMG, Comolli G, Montecucco C, Baldanti F.

J Immunol Res. 2019 Feb 17;2019:4236503. doi: 10.1155/2019/4236503. eCollection 2019.

19.

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1.

20.

Nailfold videocapillaroscopy in antisynthetase syndrome.

Cassone G, Sebastiani M, Cavagna L, Triantafyllias K, Codullo V, Salvarani C, Manfredi A.

Reumatismo. 2018 Dec 20;70(4):257-258. doi: 10.4081/reumatismo.2018.1105.

21.

"Emergency" Cochlear Implantation in Labyrinthitis Ossificans Secondary to Polyarteritis Nodosa: How to Face a Rare Entity.

Canzi P, Aprile F, Manfrin M, Avato I, Magnetto M, Minervini D, Cavagna L, Benazzo M.

J Int Adv Otol. 2019 Apr;15(1):156-159. doi: 10.5152/iao.2018.5463.

22.

One year in review 2018: idiopathic inflammatory myopathies.

Marasco E, Cioffi E, Cometi L, Valentini V, Zanframundo G, Neri R, Cavagna L, Barsotti S.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):937-947. Epub 2018 Dec 6. Review.

23.

Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study.

Sebastiani M, Triantafyllias K, Manfredi A, González-Gay MA, Palmou-Fontana N, Cassone G, Drott U, Delbrück C, Rojas-Serrano J, Bertolazzi C, Nuño L, Giannini M, Iannone F, Vicente EF, Castañeda S, Selva-O'Callaghan A, Trallero Araguas E, Emmi G, Iuliano A, Bauhammer J, Miehle N, Parisi S, Cavagna L, Codullo V, Montecucco C, Lopez-Longo FJ, Martínez-Barrio J, Nieto-González JC, Vichi S, Confalonieri M, Tomietto P, Bergner R, Sulli A, Bonella F, Furini F, Scirè CA, Bortoluzzi A, Specker C, Barsotti S, Neri R, Mosca M, Caproni M, Weinmann-Menke J, Schwarting A, Smith V, Cutolo M; American and European Network of Antisynthetase Syndrome Collaborative Group.

J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15.

PMID:
30442823
24.

Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.

Ruberto G, Bruttini C, Tinelli C, Cavagna L, Bianchi A, Milano G.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2201-2210. doi: 10.1007/s00417-018-4103-9. Epub 2018 Aug 27.

PMID:
30151601
25.

Interstitial pneumonia with autoimmune features: a new classification still on the move.

Cavagna L, Gonzalez Gay MA, Allanore Y, Matucci-Cerinic M.

Eur Respir Rev. 2018 Jun 27;27(148). pii: 180047. doi: 10.1183/16000617.0047-2018. Print 2018 Jun 30. No abstract available.

26.

Consideration of Antisynthetase Syndrome Features in Classifying Patients as Having Idiopathic Inflammatory Myopathy: Comment on the Article by Lundberg et al.

Castañeda S, Cavagna L, González-Gay MA; American and European Network of Antisynthetase Syndrome Collaborative Group.

Arthritis Rheumatol. 2018 Jun;70(6):975-976. doi: 10.1002/art.40478. Epub 2018 Apr 29. No abstract available.

27.

New Criteria Needed for Antisynthetase Syndrome.

Castañeda S, Cavagna L, González-Gay MA.

JAMA Neurol. 2018 Feb 1;75(2):258-259. doi: 10.1001/jamaneurol.2017.3872. No abstract available.

PMID:
29255888
28.

One year in review 2017: idiopathic inflammatory myopathies.

Barsotti S, Bruni C, Cometi L, Valentini V, Cioffi E, Neri R, Cavagna L.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):875-884. Epub 2017 Nov 29. Review.

PMID:
29185960
29.

Brief Report: Validation of a Definition of Flare in Patients With Established Gout.

Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS, Chen YH, Lin CT, Bourke S, Louthrenoo W, Vazquez-Mellado J, Hernández-Llinas H, Neogi T, Vargas-Santos AB, da Rocha Castelar-Pinheiro G, Amorim RBC, Uhlig T, Hammer HB, Eliseev M, Perez-Ruiz F, Cavagna L, McCarthy GM, Stamp LK, Gerritsen M, Fana V, Sivera F, Taylor W.

Arthritis Rheumatol. 2018 Mar;70(3):462-467. doi: 10.1002/art.40381. Epub 2018 Feb 6.

30.

Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria.

Cavagna L, Castañeda S, Sciré C, Gonzalez-Gay MA; AENEAS Collaborative Group Members.

Ann Rheum Dis. 2018 Aug;77(8):e50. doi: 10.1136/annrheumdis-2017-212368. Epub 2017 Sep 25. No abstract available.

PMID:
28970214
31.

Clinical spectrum of anti-Jo-1-associated disease.

Monti S, Montecucco C, Cavagna L.

Curr Opin Rheumatol. 2017 Nov;29(6):612-617. doi: 10.1097/BOR.0000000000000434. Review.

PMID:
28796005
32.

How I treat idiopathic patients with inflammatory myopathies in the clinical practice.

Cavagna L, Monti S, Caporali R, Gatto M, Iaccarino L, Doria A.

Autoimmun Rev. 2017 Oct;16(10):999-1007. doi: 10.1016/j.autrev.2017.07.016. Epub 2017 Aug 2. Review.

PMID:
28778704
33.

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49. Epub 2017 Jul 26.

34.

Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.

Capaccio P, Canzi P, Torretta S, Rossi V, Benazzo M, Bossi A, Vitali C, Cavagna L, Pignataro L.

Clin Otolaryngol. 2018 Feb;43(1):96-102. doi: 10.1111/coa.12911. Epub 2017 Jun 26.

PMID:
28585263
35.

Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies.

Scirè CA, Gonzalez-Gay MA, Selva-O'Callaghan A, Cavagna L.

Respir Med. 2017 Nov;132:265-266. doi: 10.1016/j.rmed.2017.03.028. Epub 2017 Mar 31. No abstract available.

36.

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.

Bartoloni E, Gonzalez-Gay MA, Scirè C, Castaneda S, Gerli R, Lopez-Longo FJ, Martinez-Barrio J, Govoni M, Furini F, Pina T, Iannone F, Giannini M, Nuño L, Quartuccio L, Ortego-Centeno N, Alunno A, Specker C, Montecucco C, Triantafyllias K, Balduzzi S, Sifuentes-Giraldo WA, Paolazzi G, Bravi E, Schwarting A, Pellerito R, Russo A, Selmi C, Saketkoo LA, Fusaro E, Parisi S, Pipitone N, Franceschini F, Cavazzana I, Neri R, Barsotti S, Codullo V, Cavagna L.

Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29. Review.

PMID:
28147261
37.

Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard.

Dalbeth N, Schumacher HR, Fransen J, Neogi T, Jansen TL, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Cimmino MA, Uhlig T, Taylor WJ.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1894-1898. doi: 10.1002/acr.22896. Epub 2016 Oct 28.

38.

Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard.

Ogdie A, Taylor WJ, Neogi T, Fransen J, Jansen TL, Schumacher HR, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Cagnotto G, Cavagna L, Lin C, Chou YY, Tausche AK, Lima Gomes Ochtrop M, Janssen M, Chen JH, Slot O, Lazovskis J, White D, Cimmino MA, Uhlig T, Dalbeth N.

Arthritis Rheumatol. 2017 Feb;69(2):429-438. doi: 10.1002/art.39959.

39.

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.

Cavagna L, Codullo V, Ghio S, Scirè CA, Guzzafame E, Scelsi L, Rossi S, Montecucco C, Caporali R.

Medicine (Baltimore). 2016 Sep;95(39):e4827. doi: 10.1097/MD.0000000000004827.

40.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA; AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9. Review.

PMID:
26782036
41.

Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Ralph Schumacher H, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

J Rheumatol. 2016 Jan;43(1):150-3. doi: 10.3899/jrheum.150684. Epub 2015 Dec 1.

PMID:
26628602
42.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Murcia TP, La Corte R, Furini F, Foschi V, Corral JB, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Montecucco C, González-Gay MA; AENEAS (American, European NEtwork of Antisynthetase Syndrome) collaborative group.

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

43.

Genetics and novel aspects of therapies in systemic lupus erythematosus.

Relle M, Weinmann-Menke J, Scorletti E, Cavagna L, Schwarting A.

Autoimmun Rev. 2015 Nov;14(11):1005-18. doi: 10.1016/j.autrev.2015.07.003. Epub 2015 Jul 9. Review.

PMID:
26164648
44.

Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference.

Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G, Franceschini F, Allegri L, Pratesi F, Migliorini P, Candiano G, Pesce G, Ravelli A, Puppo F, Martini A, Tincani A, Ghiggeri GM.

Autoimmun Rev. 2015 Aug;14(8):692-702. doi: 10.1016/j.autrev.2015.04.004. Epub 2015 Apr 14. Review.

PMID:
25888464
45.

Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout.

Taylor WJ, Fransen J, Jansen TL, Dalbeth N, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, Vargas-Santos AB, Janssen M, Chen JH, Slot O, Cimmino MA, Uhlig T, Neogi T.

Arthritis Care Res (Hoboken). 2015 Sep;67(9):1304-1315. doi: 10.1002/acr.22585.

46.

Performance of classification criteria for gout in early and established disease.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

Ann Rheum Dis. 2016 Jan;75(1):178-82. doi: 10.1136/annrheumdis-2014-206364. Epub 2014 Oct 28.

PMID:
25351521
47.

Biotechnological drugs: the breakthrough in autoimmune rheumatic conditions.

Cavagna L, Saketkoo LA, Schwarting A, Caporali R.

Biomed Res Int. 2014;2014:481973. doi: 10.1155/2014/481973. Epub 2014 Aug 10. No abstract available.

48.

Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry.

Filippini M, Bazzani C, Atzeni F, Sarzi Puttini P, Marchesoni A, Favalli EG, Caporali R, Cavagna L, Gorla R.

Biomed Res Int. 2014;2014:416892. doi: 10.1155/2014/416892. Epub 2014 Jul 6.

49.

Colony-stimulating factor-1: a potential biomarker for lupus nephritis.

Menke J, Amann K, Cavagna L, Blettner M, Weinmann A, Schwarting A, Kelley VR.

J Am Soc Nephrol. 2015 Feb;26(2):379-89. doi: 10.1681/ASN.2013121356. Epub 2014 Jul 10.

50.

A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria.

Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia GL.

Autoimmun Rev. 2014 Nov;13(11):1142-8. doi: 10.1016/j.autrev.2014.05.009. Epub 2014 May 29. Review.

PMID:
24879966

Supplemental Content

Loading ...
Support Center